Skip to main content

Breadcrumb

  1. Home

Claims Data

Valid for Measure Submission

Rheumatoid Arthritis New DMARD Baseline Serum Creatinine

  • This measure identifies adult patients with a diagnosis of rheumatoid arthritis who received appropriate baseline serum creatinine testing within 90 days before to 14 days after the new start of methotrexate, leflunomide, azathioprine, D-Penicillamine, intramuscular gold, cyclosporine, or cyclophosphamide during the measurement year.

    CBE ID
    0589

Risk Adjusted Post-Ambulance Provider Triage Emergency Department (ED) Visit Rate Measure

  • The Risk Adjusted Post-Ambulance Provider Triage Emergency Department (ED) Visit Rate Measure (shorthand: Post-Triage ED Visit Rate Measure) assesses the quality of the triage and decision making by ambulance providers who transport low acuity patients to an alternative destination (non-ED location), or facilitate Treatment In Place (TIP), by identifying whether patients have a subsequent ED visit or death within three days.

    CBE ID
    3751

Risk-Adjusted 30-Day All-Cause Readmission Rate

  • The existing NQF-endorsed measure provides a means for determining the risk-adjusted readmission rate for a selected adult target population and can be applied for any desired timeframe. Readmission rate is defined as the percentage of acute inpatient discharges during the measurement period followed by an acute inpatient admission for any diagnosis to any hospital within 30 days

    CBE ID
    0329

Risk-Adjusted Coronary Artery Bypass Graft (CABG) Readmission Rate

  • Risk-adjusted percentage of Medicare fee-for-service beneficiaries aged 65 and older who undergo isolated coronary artery bypass grafting (CABG) and are discharged alive but have a subsequent acute care hospital inpatient admission within 30 days of the date of discharge from the CABG hospitalization.

    CBE ID
    2514